Latest KFF Health News Stories
Best Reads Of The Week With Brianna Labuskes
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
Why Did Novartis Pay Trump’s Lawyer $1.2 Million? Look At Its Drug Prices
Promises to control pharma prices threaten profits for Switzerland-based Novartis, which sells some of the costliest drugs in the world.
Nueva tendencia: las parejas de adultos mayores que viven separadas
Cada vez más adultos mayores deciden estar en relaciones sentimentales sin vivir con su pareja. Dicen que el compromiso es el mismo, pero que valoran su tiempo solos.
Por plan de Trump, inmigrantes podrían tener miedo de recibir beneficios de salud
Bajo la norma propuesta, el que un immigrante haya usado beneficios públicos como Medicaid o SNAP, puede poner en peligro el proceso para obtener la residencia permanente.
Consumers Brace For Premium Hikes While Lawmakers Grasp At Remedies
Health insurers’ initial premium requests indicate stiff price hikes for consumers, just as bipartisan talks in Congress fall flat.
Editorial writers focus on these and other health topics.
The Opioid Crisis: We Shouldn’t Have To Ration Anti-Overdose Medication In Midst Of An Epidemic
Writers offer perspectives on the opioid crisis.
As Mother’s Day approaches, columnists offer their opinions on women’s health care.
Research Roundup: Pain Management; Zika Testing In Blood Donations
Each week, KHN compiles a selection of recently released health policy studies and briefs.
Media outlets report on news from Massachusetts, Colorado, North Carolina, California, Missouri, Indiana, Florida, Oregon, Wisconsin, Iowa, Wyoming, Louisiana, Arizona and Pennsylvania.
Law Enforcement Often Bearing Weight Of Failed Mental Health Systems
The Des Moines Register examines Iowa’s mental health crisis and where law enforcement is having to step in to fill the gaps the system has created.
No one should ever “second-guess” themselves if they think they are experiencing the symptoms of a heart attack. Along with chest pain and fatigue, symptoms can include neck, jaw, back or abdominal pain.
The improvements are more subtle than early visions of AI curing cancer, but experts say changes are benefiting patients. In other public health news: cancer drugs, anxiety, e-cigarettes, fatal falls, kidney stones, and more.
“The big takeaway is we need more research, plain and simple,” said Dr. Ilana Braun of Dana-Farber Cancer Institute in Boston, who led the study published Thursday in the Journal of Clinical Oncology.
Global Health Security Team Disbanded After Departure Of Official Overseeing Pandemic Preparedness
The moves come at a time when experts are already warning that the country is underprepared to handle a major public health crisis.
Feeling Marginalized In Massive Opioid Lawsuit, Native Americans Request Own Day In Court
Native American tribes are among those the opioid epidemic has hit the hardest, though scant attention has been paid to how the crisis is ripping through their communities. At least 20 tribes have formally sued opioid manufacturers and distributors, with at least 10 more suits expected to be filed soon. In other news on the crisis: discarded syringes; staffing shortages’ effects on regulating opioids coming into the country; the impact of the epidemic on rural communities; and more.
New enthusiasm for adding work requirements to states’ Medicaid program is running headlong into Native American rights. HHS’ legal office has made the judgment that exempting Native Americans from the rules would be an illegal racial preference. But some other agency officials and Republicans in Congress don’t share that view. Meanwhile, one GOP lawmaker is calling for mandatory work requirements for all Medicaid beneficiaries.
Tennessee Bill Will Allow Drug Companies To Market Their Products For Off-Label Uses
Pharmaceutical companies traditionally have been restricted from distributing information about off-label uses to doctors, which they say is a violation of free speech. Critics, however, are worried that more freedom for the drugmakers could jeopardize patient safety.
More details are emerging over what the drug company paid to try to gain insight into President Donald Trump’s health strategy. CEO Vasant Narasimhan wrote to employees that he understood they felt “disappointed and frustrated.”
Short-Term Plans Are Same Ones Obama Had For Eight Years, HHS Secretary Says In Face Of Criticism
Democrats say the Trump administration’s proposal to extend short-term plans will weaken the marketplace by allowing healthy people to buy coverage that’s not compliant with the health law. But HHS Secretary Alex Azar says it’s just returning to a status quo that only changed in 2017. Meanwhile, President Donald Trump hints the White House has some “great health plans” coming out in the next few weeks, but didn’t go into details.